JP2022177119A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022177119A5 JP2022177119A5 JP2022144243A JP2022144243A JP2022177119A5 JP 2022177119 A5 JP2022177119 A5 JP 2022177119A5 JP 2022144243 A JP2022144243 A JP 2022144243A JP 2022144243 A JP2022144243 A JP 2022144243A JP 2022177119 A5 JP2022177119 A5 JP 2022177119A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- administration
- drug
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025044178A JP2025098099A (ja) | 2019-12-06 | 2025-03-19 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944674P | 2019-12-06 | 2019-12-06 | |
| US62/944,674 | 2019-12-06 | ||
| US202063077996P | 2020-09-14 | 2020-09-14 | |
| US63/077,996 | 2020-09-14 | ||
| US202063109698P | 2020-11-04 | 2020-11-04 | |
| US63/109,698 | 2020-11-04 | ||
| JP2021557408A JP7142173B2 (ja) | 2019-12-06 | 2020-12-03 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
| PCT/US2020/063089 WO2021113497A1 (en) | 2019-12-06 | 2020-12-03 | Dosing of a bruton's tyrosine kinase inhibitor |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557408A Division JP7142173B2 (ja) | 2019-12-06 | 2020-12-03 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025044178A Division JP2025098099A (ja) | 2019-12-06 | 2025-03-19 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022177119A JP2022177119A (ja) | 2022-11-30 |
| JP2022177119A5 true JP2022177119A5 (cg-RX-API-DMAC7.html) | 2023-10-31 |
| JP7654604B2 JP7654604B2 (ja) | 2025-04-01 |
Family
ID=73854977
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557408A Active JP7142173B2 (ja) | 2019-12-06 | 2020-12-03 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
| JP2022144243A Active JP7654604B2 (ja) | 2019-12-06 | 2022-09-12 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
| JP2025044178A Pending JP2025098099A (ja) | 2019-12-06 | 2025-03-19 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557408A Active JP7142173B2 (ja) | 2019-12-06 | 2020-12-03 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025044178A Pending JP2025098099A (ja) | 2019-12-06 | 2025-03-19 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12551463B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4069219A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7142173B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20220100992A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115175677A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2020397034B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022009716A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL292882B1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022006631A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021113497A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3108065C (en) | 2018-07-31 | 2025-10-07 | Loxo Oncology, Inc. | SPRAY-DRIED DISPERSIONS, FORMULATIONS AND POLYMORPHIES OF (S)-5-AMINO-3-(4-((5-FLUORO-2-METHOXYBENZAMIDO)METHYL)PHENYL)(1,1,1-TRIFLUOROPROPANE-2-YL)-1H-PYRAZOLE-4-CARBOXAMIDE |
| KR20220100992A (ko) * | 2019-12-06 | 2022-07-18 | 록쏘 온콜로지, 인코포레이티드 | 브루톤 티로신 키나제 억제제의 투여 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2529621B1 (en) | 2006-09-22 | 2016-10-05 | Pharmacyclics LLC | Inhibitors of bruton's tyrosine kinase |
| US20150291554A1 (en) | 2012-11-02 | 2015-10-15 | Pfizer Inc. | Bruton's Tyrosine Kinase Inhibitors |
| US9717745B2 (en) | 2015-03-19 | 2017-08-01 | Zhejiang DTRM Biopharma Co. Ltd. | Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases |
| CN114605327B (zh) * | 2015-12-16 | 2025-03-11 | 洛克索肿瘤学股份有限公司 | 可用作激酶抑制剂的化合物 |
| WO2017132474A1 (en) | 2016-01-30 | 2017-08-03 | Newave Pharmaceutical Inc. | Bcl-2 inhibitors |
| KR102376764B1 (ko) | 2016-08-05 | 2022-03-18 | 더 리젠츠 오브 더 유니버시티 오브 미시건 | Bcl-2 억제제로서의 n-(페닐설포닐)벤즈아미드 및 관련 화합물 |
| CN110177788B (zh) | 2017-01-07 | 2023-03-24 | 重庆复创医药研究有限公司 | 作为bcl-2选择性凋亡诱导剂的化合物 |
| SI3612531T1 (sl) | 2017-04-18 | 2022-11-30 | Shanghai Fochon Pharmaceutical Co., Ltd. | Sredstva, ki sprožajo apoptozo |
| JP2020528061A (ja) | 2017-07-26 | 2020-09-17 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | BET阻害剤、Bcl−2阻害剤及び抗CD20抗体を用いた併用療法 |
| IL316472A (en) | 2018-01-10 | 2024-12-01 | Recurium Ip Holdings Llc | Benzamide compounds |
| CN112437772B (zh) | 2018-04-29 | 2023-11-21 | 百济神州有限公司 | Bcl-2抑制剂 |
| CA3108065C (en) | 2018-07-31 | 2025-10-07 | Loxo Oncology, Inc. | SPRAY-DRIED DISPERSIONS, FORMULATIONS AND POLYMORPHIES OF (S)-5-AMINO-3-(4-((5-FLUORO-2-METHOXYBENZAMIDO)METHYL)PHENYL)(1,1,1-TRIFLUOROPROPANE-2-YL)-1H-PYRAZOLE-4-CARBOXAMIDE |
| KR20220100992A (ko) * | 2019-12-06 | 2022-07-18 | 록쏘 온콜로지, 인코포레이티드 | 브루톤 티로신 키나제 억제제의 투여 |
-
2020
- 2020-12-03 KR KR1020227022407A patent/KR20220100992A/ko not_active Ceased
- 2020-12-03 US US17/782,758 patent/US12551463B2/en active Active
- 2020-12-03 KR KR1020237028538A patent/KR20230127372A/ko active Pending
- 2020-12-03 CN CN202080095816.0A patent/CN115175677A/zh active Pending
- 2020-12-03 IL IL292882A patent/IL292882B1/en unknown
- 2020-12-03 JP JP2021557408A patent/JP7142173B2/ja active Active
- 2020-12-03 EP EP20825385.6A patent/EP4069219A1/en active Pending
- 2020-12-03 AU AU2020397034A patent/AU2020397034B2/en active Active
- 2020-12-03 WO PCT/US2020/063089 patent/WO2021113497A1/en not_active Ceased
- 2020-12-03 MX MX2022006631A patent/MX2022006631A/es unknown
- 2020-12-03 BR BR112022009716A patent/BR112022009716A2/pt unknown
-
2022
- 2022-09-12 JP JP2022144243A patent/JP7654604B2/ja active Active
-
2024
- 2024-02-26 AU AU2024201263A patent/AU2024201263B2/en active Active
-
2025
- 2025-03-19 JP JP2025044178A patent/JP2025098099A/ja active Pending